BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2022 9:40:09 AM | Browse: 660 | Download: 1598
 |
Received |
|
2021-04-15 20:09 |
 |
Peer-Review Started |
|
2021-04-15 20:12 |
 |
First Decision by Editorial Office Director |
|
2021-06-04 00:58 |
 |
Return for Revision |
|
2021-06-04 00:58 |
 |
Revised |
|
2021-08-24 23:18 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-03-22 06:26 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-03-27 07:00 |
 |
Articles in Press |
|
2022-03-27 07:00 |
 |
Edit the Manuscript by Language Editor |
|
2022-03-18 18:02 |
 |
Typeset the Manuscript |
|
2022-04-01 11:15 |
 |
Publish the Manuscript Online |
|
2022-04-15 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chrysanthos D Christou and Georgios Tsoulfas |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Georgios Tsoulfas, MD, PhD, Associate Professor, Surgeon, Department of Transplantation Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, Thessaloniki 54622, Greece. tsoulfasg@gmail.com |
| Key Words |
Artificial intelligence; Machine learning; Three-dimensional printing; Bioprinting; Hepatocellular carcinoma; Liver cancer |
| Core Tip |
The opportunities that arise from the application of three-dimensional (3D) printing and 3D bioprinting in the management of hepatocellular carcinoma (HCC) include resident education, patient education, preoperative planning, fabrication of custom-made medical tools, liver models for antitumor drug development, and patient-derived HCC models for targeted treatment selection. Similarly, the opportunities that arise from the application of artificial intelligence/machine learning in the management of HCC include targeted screening for patients with chronic hepatitis B and C infections, non-invasive early detection of HCC, increased diagnostic accuracy, frameworks for evidence-based, individualized treatment allocation, and prognostic models for the prediction of patient outcomes including overall survival, disease-free survival, and recurrence that could be used for patient and family counseling. |
| Publish Date |
2022-04-15 09:40 |
| Citation |
Christou CD, Tsoulfas G. Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities. World J Gastrointest Oncol 2022; 14(4): 765-793 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i4/765.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i4.765 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.